Development and accuracy evaluation of a new loop-mediated isothermal amplification assay targeting the HSP70 gene for the diagnosis of cutaneous leishmaniasis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306967 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Arthur Ribeiro Cheloni Soares und 2 weiteren Autor:innen. Beteiligte Einrichtung: Instituto René Rachou, Fundação Oswaldo Cruz, Grupo de Pesquisa Clínica e Políticas Públicas em Doenças Infecciosas e Parasitárias, CEP: 30190-002, B…. Hauptthemen laut MEDLINE: HSP70 Heat-Shock Proteins, Leishmaniasis, Cutaneous, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Cientifico e Tecnológico, Brasil.
Abstract (Originalsprache)
Cutaneous leishmaniasis (CL) is a global public health problem caused by species on the genus Leishmania and is the most prevalent clinical form of leishmaniasis. The aim of this study was to develop a new LAMP assay for Leishmania sp. based on HSP70 gene and evaluate it clinically for molecular diagnosis of CL. The study was carried out in the following stages: i) design of primers based on HSP70 gene of Leishmania sp.; ii) evaluation of detection limit and analytical specificity; iii) estimation of the accuracy of LAMP-Leish/HSP70 assay for diagnosing CL. A total of 100 skin biopsy samples from patients, comprising 60 CL cases and 40 non-cases, were analyzed in this study. One LAMP assay using HSP70 gene as molecular target were standardized, and the observed detection limit was 100fg of L . braziliensis purified DNA. The LAMP-Leish/HSP70 assay was specific for Leishmania spp. The LAMP-Leish/HSP70 assay showed an accuracy of 92%, and positivity rates were not affected by lesion onset time or parasite load. This novel LAMP assay targeting the HSP70 gene of Leishmania sp. has the potential to be a useful tool to integrate into routine diagnosis for suspected cases of CL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto René Rachou, Fundação Oswaldo Cruz, Grupo de Pesquisa Clínica e Políticas Públicas em Doenças Infecciosas e Parasitárias, CEP: 30190-002, Belo Horizonte, Minas Gerais, Brazil.
ORCID-Profile: Daniel Moreira de Avelar
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento Cientifico e Tecnológico, Brasil
Zitieren
APA
Soares, A. R. C., Faria, V. C. S., & Avelar, D. M. (2024). Development and accuracy evaluation of a new loop-mediated isothermal amplification assay targeting the HSP70 gene for the diagnosis of cutaneous leishmaniasis. PLOS ONE. https://doi.org/10.1371/journal.pone.0306967
Vancouver
Soares ARC, Faria VCS, Avelar DM. Development and accuracy evaluation of a new loop-mediated isothermal amplification assay targeting the HSP70 gene for the diagnosis of cutaneous leishmaniasis. PLOS ONE. 2024. doi:10.1371/journal.pone.0306967
BibTeX
@article{Soares2024,
author = {Soares, Arthur Ribeiro Cheloni and Faria, Verônica Cardoso Santos de and Avelar, Daniel Moreira de},
title = {Development and accuracy evaluation of a new loop-mediated isothermal amplification assay targeting the HSP70 gene for the diagnosis of cutaneous leishmaniasis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306967}
}
EUVIMED